Sara Nik

Stock Analyst at HC Wainwright & Co.

(n/a)

# 433

Out of 5,182 analysts

6

Total ratings

16.67%

Success rate

-43.42%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MBRX Moleculin Biotech	Reiterates: Buy	$22	$2.49	+783.53%	4	Mar 24, 2026
	CRIS Curis	Reiterates: Buy	$17	$0.62	+2,621.31%	1	Mar 20, 2026
	KTTA Pasithea Therapeutics	Initiates: Buy	$3	$0.79	+279.75%	1	Dec 8, 2025

Moleculin Biotech

Mar 24, 2026

Reiterates: Buy

Price Target: $22

Current: $2.49

Upside: +783.53%

Curis

Mar 20, 2026

Reiterates: Buy

Price Target: $17

Current: $0.62

Upside: +2,621.31%

Pasithea Therapeutics

Dec 8, 2025

Initiates: Buy

Price Target: $3

Current: $0.79

Upside: +279.75%